Amgen Inc (AMGN) stock
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3026% above fair value
$443.89−14.04 (-3.07%)
Close on Nov 18, 2026Market cap $239.98BP/E 25.7Yield 2.18%
Amgen price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Amgen's price to book ratio was 21.7× on Nov 11, 2026, against 19.3× a year earlier. Over the last 5 years it ranged from 15.5× to 149.7×, with a median of 22.6×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 21.7× | +3.3 |
| 2025 | Dec 31, 2025 | 18.3× | −0.3 |
| 2024 | Dec 31, 2024 | 18.6× | −1.5 |
| 2023 | Dec 29, 2023 | 20.1× | −18.2 |
| 2022 | Dec 30, 2022 | 38.4× | +22.9 |
| 2021 | Dec 31, 2021 | 15.5× | +3.2 |
| 2020 | Dec 31, 2020 | 12.2× | −1.2 |
| 2019 | Dec 31, 2019 | 13.4× | +4.6 |
| 2018 | Dec 31, 2018 | 8.8× | +4.9 |
| 2017 | Dec 29, 2017 | 3.9× | +0.4 |
| 2016 | Dec 30, 2016 | 3.5× | −0.8 |
| 2015 | Dec 31, 2015 | 4.4× | −0.4 |
| 2014 | Dec 31, 2014 | 4.8× | +0.8 |
| 2013 | Dec 31, 2013 | 4.0× | +0.6 |
| 2012 | Dec 31, 2012 | 3.3× | +0.9 |
| 2011 | Dec 30, 2011 | 2.4× | +0.2 |
| 2010 | Dec 31, 2010 | 2.2× | −0.3 |
| 2009 | Dec 31, 2009 | 2.5× | – |
See a number that looks wrong?